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C. Carpenter, H. Liu, C. Sun, G. Pratx, Z. Chang, and L. Xing; Stanford
University, Stanford, CA
Purpose/Objective(s): Real-time feedback, identifying both tumor loca-
tion and radiation dose,would be beneficial during interventional procedures
such as glioma brain tumor resection.We investigated the feasibility of using
a fiber-based Cerenkov imaging system to detect tumor margins in the
surgical resection cavity invivo. The potential benefit of a Cerenkov imaging
is its ability to image tumor cells by their preferential uptake of radiotracers
such as FDG, and the additional ability to visualize radiation treatment in
real-time. We investigated the performance of Cerenkov imaging for these
goals both in phantoms and in vivo in a tumor mouse model.
Materials/Methods: Experiments were performed in a dark chamber
through an optical fiber bundle and imaged by a charge-coupled device
(CCD) camera or an optical detector. Cerenkov luminescence was recorded
from 5 mice bearing subcutaneous C6 glioma cells with intravenous
injection of 18F-FDG. The tumor tissues were exposed and CLI was
performed on the mouse before and after surgical removal of the tumor
using the fiber-based imaging system and compared to a commercial
optical imaging system. Separately, phantoms were irradiated with a linear
accelerator with 9MeV electrons.
Results: Tumor tissues showed significant preferential uptake of FDG vs.
normal tissues, with nearly a 20% increase. After tumor removal, Cerenkov
signal from the surgical cavity dropped to the noise level. In addition, the
Cerenkov signal arising from the phantom indicated irradiation.
Conclusion: This proof-of-concept study explored the feasibility of using
fiber-based CLE for the detection of tumor tissue in vivo for guided
treatment. With further improvements of imaging sensitivity and spatial
resolution of the current system, CLE may have a significant application in
the clinical setting in the near future.
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Purpose/Objective(s): Monte Carlo (MC) method can accurately
compute the dose produced by medical linear accelerators. However, these
calculations require a reliable description of the electron and/or photon
beams delivering the dose, the phase space (PHSP), which is not usually
available. A method to derive a phase space model from reference
measurements that does not heavily rely on a detailed model of the
accelerator head is presented. The iterative optimization process extracts
the characteristics of the particle beams which best explains the reference
dose measurements in water and air, given a set of constrains.
Materials/Method: Beams with cylindrical symmetry, as the ones
employed in intraoperative radiation therapy (IORT) are assumed. The
particle type, energy, radial position of emission and angle with respect to
the applicator axis are the only relevant variables of each particle trajec-
tory. All these variables are considered during optimization, contrary to
other approaches which optimize a reduced set of variables or even onlythe energy. The PHSP is discretized into 250000 bins whose individual
contribution is estimated by an iterative expectation maximization of the
maximum likelihood algorithm (EM-ML) comparing reference measure-
ments to the dose produced by the PHSP. The absorbed dose distributions
were simulated using a parallel version of the MC code Dose Planning
Method (DPM), which allows for fast computation of doses, obtained as
linear combinations of the dose produced by the elemental bin sources.
Convergence of the algorithm for a set of data for a given energy is usually
reached after 150 iterations, which takes less than two hours using 16
threads on a 8 physical cores computer (dual Intel E5620@2,4 GHz, 48
GB RAM). Full simulations of realistic accelerator heads provided
reasonable constrains on the PHSP that the iterative algorithm should
explore. The PHSP obtained have been incorporated in an IOERT dedi-
cated treatment planning system.
Results: Phase space files have been derived for different energies and
LINAC systems, both in electron and photon mode. Agreement with the
reference data employed in the fit was very good. Once data in two
different materials (water and air) are included in the fit, test challenges
against known PHSP were successfully performed. Agreement with data
not included in the optimization procedure is fair.
Conclusions: Reasonable PHSP can be obtained if enough computational
resources and reference data on different materials are available. The
method proposed is a new and powerful technique that potentially can be
employed to obtain PHSP files for any accelerator for radiation therapy.
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Purpose/Objective(s): Lung cancer is one of the most frequent lethal
cancers, giving a 5 year survival rate of 20%. Local tumor failure
following radiation is common. However, higher radiation doses (120 Gy)
yield a higher local control rate (90%). Molecular imaging studies reveal
tumor heterogeneity which may explain therapeutic resistance. Hence the
use of 18F-FDG to dose paint lung tumors is a viable strategy . We
hypothesize that a functional fit to the SUV uptake distribution represents
the intrinsic heterogeneity of the tumor and this function could be used for
dose painting. Alternatively, variations observed in the SUV uptake may
not be due to the intrinsic heterogeneity of the tumor, but due to effects of
PET position resolution (volume dependence) or tumor motion. The
objective of this study is to derive a functional form of SUV uptake by
eliminating resolution and motion effects.
Materials/Methods: We conducted a patient and a phantom study: I.
Patient study: 25 peripheral NSCLC tumors with motion amplitudes less
than 5mm, and tumor volumes of 5cc to 550cc. PET SUVuptake values for
each tumor were fit with a Woods-Saxon model with 2 parameters: radius
and skin depth. When the ratio of radius to skin depth becomes small, this
simplifies to a Gaussian. II. Phantom study: spheres of homogeneous18F-
FDG activity of motion amplitudes (0, 5, 10, 15, 20, 25, 30 mm) and
volumes (internal diameter 10, 13, 17, 22, 28, 37 mm). Any variation
observed in SUV uptake distribution with homogeneous activity spheres
must be due to motion and volume effects. Therefore, we used this data to
quantify uptake variations as a function of motion and volume.
Results: The patient study shows that for small tumors up to about 45cc,
SUV uptakes can be described by a Gaussian distribution in all three
dimensions, peaking at center and dropping as distance from center
increases. For Intermediate tumor volumes (50 cc to 200 cc) SUV uptakes
show a flat central region surrounded by a skin region over which activity
drops. For large tumors, (> 200 cc) SUVuptakes are low in the center of the
tumor, and higher in the surrounding shell before dropping at the edge.
Phantom study for stationary spheres shows that for volumes larger than 5 cc,
